Skip to content
HHS’s big picture for health AI

HHS’s big picture for health AI

Plus: Anthropic's record IPO, Epic opens the door to AI developers, Hims and Noom enter the peptide market, and Four Questions with Tom Health's John Fryer.
• 14 min read •

The lead

Ruth’s take

Ruth Reader

This week Chrissy and I were both at HLTH, talking shop and gathering everyone’s thoughts on what’s going on in health tech. My main takeaway? There’s a lot of excitement about AI’s potential and a lot of questions about what shape regulation will take in 2027.

The Department of Health and Human Services is currently firing the mold for AI safety and practice. It has a clear vision: super intelligent technology should be able to assist and augment the way health care is delivered in the U.S. such that it lowers chronic disease in the country and contracts seemingly ever expanding costs.

Last week, the Center for Medicare and Medicaid Services issued its roadmap for health care “Super Intelligence,” which I wrote about here. In it, the agency describes how HHS has so far prepped the canvas, by bringing together market participants via its health tech ecosystem, turning on a way of paying for SI-enabled care through its experimental ACCESS program, and creating a mechanism for oversight via the Food and Drug Administration’s TEMPO program.

Next, it wants to create a data foundation on which health apps can deliver actionable health advice so patients can manage their own health. A piece of that plan came together this week when the Office of Civil Rights dropped the final HIPAA privacy rule. The new rule makes it easier for patients to use health apps as an emissary, to gather their records for them, while limiting the circumstances under which providers and insurers can push back on those requests.

`

Upcoming Sessions

Live conversations with the people shaping healthcare.

View all →

Share this article

Spread the word